Visus Therapeutics
Biotechnology, 500 Yale Ave N, Seattle, Washington, 98109, United States, 11-50 Employees
Who is VISUS THERAPEUTICS
With offices in Seattle, Wash., and Irvine, Calif., Visus Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision f...
Read More
-
Headquarters: 500 Yale Ave N, Seattle, Washington, 98109, United States
-
Date Founded: 2019
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from VISUS THERAPEUTICS
Visus Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Visus Therapeutics
Answer: Visus Therapeutics's headquarters are located at 500 Yale Ave N, Seattle, Washington, 98109, United States
Answer: Visus Therapeutics's official website is https://visustx.com
Answer: Visus Therapeutics's revenue is $10 Million to $25 Million
Answer: Visus Therapeutics's SIC: 2834
Answer: Visus Therapeutics's NAICS: 325412
Answer: Visus Therapeutics has 11-50 employees
Answer: Visus Therapeutics is in Biotechnology
Answer: Visus Therapeutics contact info: Phone number: Website: https://visustx.com
Answer: With offices in Seattle, Wash., and Irvine, Calif., Visus Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world. The company is developing novel miotic formulations for a once-daily eye drop to correct the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates with applications in ocular surface disease, glaucoma and age-related macular degeneration. Additionally, Visus Therapeutics has entered into a worldwide exclusive licensing agreement with DelSiTech Ltd, a leader in advanced, biodegradable, silica-based, controlled-release materials, to develop novel drug delivery technology that can help optimize the clinical benefit of ophthalmic therapies.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month